“prostate-cancer” Archives

in
Entry Author Date Location
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
AbbVie Wins First FDA Approval of Drug to Treat Uterine Fibroid Bleeds 05/29/20 National
Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact 05/27/20 San Francisco
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
Lantern Pharma IPO File Illuminates Plan to “Rescue” Failed Cancer Drugs 04/17/20 Texas
Scripps Research’s Calibr to Test “Switchable” CAR-T in Clinical Trial 02/06/20 San Diego
Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More 11/22/19 National
Kronos Bio Reels In $105M for Drugs That Hit “Undruggable” Targets 07/18/19 San Francisco
Bayer and Arvinas Join Forces in $115M Pharma & Ag Research Alliance 06/04/19 Boston
Emtora Biosciences Turns Sights on Rare Genetic Disease, New Funding 04/30/19 Texas
Hookipa’s IPO Raises $84M for Drugs to Reprogram the Immune System 04/18/19 New York
Blood Test Study Meets Goal, Validates Epic’s Prostate Cancer Target 03/13/19 San Diego
Rapamycin Holdings Changes Name to Emtora Biosciences, Hires New CEO 02/26/19 Texas
Harpoon’s IPO Spears $76M as Prostate Cancer Drug Continues Testing 02/07/19 San Francisco
Poseida Therapeutics Prepares for IPO to Advance CAR-T Treatments 01/04/19 San Diego
Bio Roundup: 2019 Trials, Pilgrim Price Chat, Pre-Xmas Sales & More 12/21/18 National
Sophiris, Stock Sliding After Cancer Drug Data, Still Plans Phase 3 12/17/18 San Diego
Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive’s End 10/19/18 National
Novartis Buys Endocyte for $2.1B, Making a Second Bet on Radiotherapy 10/18/18 Indiana
Sutro Biopharma, Arvinas Are Latest to Tee Up Biotech IPOs 08/30/18 San Francisco
Hyperloop, Cellectar, Cheeks & More: This Week’s Wisconsin Watchlist 07/16/18 Wisconsin
Gregor Diagnostics Raises $900K to Develop New Prostate Cancer Test 07/10/18 Wisconsin
Bio Roundup: Dunsire’s Danish, Price Hikes, Rare-Disease Race & More 07/06/18 National
Study: Blood Test for Prostate Cancer Can Guide Therapy, Extend Lives 07/02/18 San Diego
Bio-Techne to Acquire Liquid Biopsy Firm Exosome Diagnostics for $250M 06/25/18 Boston
BioAffinity Seeking $5M for Cancer Diagnostic, Adds Board Member 05/15/18 Texas
Rapamycin Holdings Plans Tests of Old Immune Drug in Prostate Cancer 05/09/18 Texas
Life Sci Veteran Garabedian Talks Up Biotech Accelerator in Texas 04/23/18 Texas
With IPO, BioXcel Looks to Fund AI-Fueled Drug Discovery Work 02/14/18 New York
Armune Bio’s Cancer Detection Tech Finds New Home with Exact Sciences 01/26/18 Detroit Ann Arbor
Page 1 of 10 next page »